BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

565 related articles for article (PubMed ID: 26770668)

  • 1. Eosinophilic airway inflammation: role in asthma and chronic obstructive pulmonary disease.
    George L; Brightling CE
    Ther Adv Chronic Dis; 2016 Jan; 7(1):34-51. PubMed ID: 26770668
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Molecular markers of type 2 airway inflammation are similar between eosinophilic severe asthma and eosinophilic chronic obstructive pulmonary disease.
    Fricker M; McDonald VM; Winter NA; Baines KJ; Wark PAB; Simpson JL; Gibson PG
    Allergy; 2021 Jul; 76(7):2079-2089. PubMed ID: 33470427
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Eosinophilic and Neutrophilic Airway Inflammation in the Phenotyping of Mild-to-Moderate Asthma and Chronic Obstructive Pulmonary Disease.
    Górska K; Paplińska-Goryca M; Nejman-Gryz P; Goryca K; Krenke R
    COPD; 2017 Apr; 14(2):181-189. PubMed ID: 27983888
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Eosinophilic chronic obstructive pulmonary disease: A review].
    Anaev EK
    Ter Arkh; 2023 Oct; 95(8):696-700. PubMed ID: 38158908
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Sputum IL-25, IL-33 and TSLP, IL-23 and IL-36 in airway obstructive diseases. Reduced levels of IL-36 in eosinophilic phenotype.
    Moermans C; Damas K; Guiot J; Njock MS; Corhay JL; Henket M; Schleich F; Louis R
    Cytokine; 2021 Apr; 140():155421. PubMed ID: 33486314
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Inflammatory Endotype-associated Airway Microbiome in Chronic Obstructive Pulmonary Disease Clinical Stability and Exacerbations: A Multicohort Longitudinal Analysis.
    Wang Z; Locantore N; Haldar K; Ramsheh MY; Beech AS; Ma W; Brown JR; Tal-Singer R; Barer MR; Bafadhel M; Donaldson GC; Wedzicha JA; Singh D; Wilkinson TMA; Miller BE; Brightling CE
    Am J Respir Crit Care Med; 2021 Jun; 203(12):1488-1502. PubMed ID: 33332995
    [No Abstract]   [Full Text] [Related]  

  • 7. Disease burden of eosinophilic airway disease: Comparing severe asthma, COPD and asthma-COPD overlap.
    Hiles SA; Gibson PG; McDonald VM
    Respirology; 2021 Jan; 26(1):52-61. PubMed ID: 32428971
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Anti-IL-5 therapies for chronic obstructive pulmonary disease.
    Donovan T; Milan SJ; Wang R; Banchoff E; Bradley P; Crossingham I
    Cochrane Database Syst Rev; 2020 Dec; 12(12):CD013432. PubMed ID: 33295032
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Eosinophilic airway inflammation in COPD.
    Saha S; Brightling CE
    Int J Chron Obstruct Pulmon Dis; 2006; 1(1):39-47. PubMed ID: 18046901
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Role of eosinophils in airway inflammation of chronic obstructive pulmonary disease.
    Tashkin DP; Wechsler ME
    Int J Chron Obstruct Pulmon Dis; 2018; 13():335-349. PubMed ID: 29403271
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Induced sputum, eosinophilic bronchitis, and chronic obstructive pulmonary disease.
    Hargreave FE; Leigh R
    Am J Respir Crit Care Med; 1999 Nov; 160(5 Pt 2):S53-7. PubMed ID: 10556171
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Eosinophilic airway disorders.
    Scott KA; Wardlaw AJ
    Semin Respir Crit Care Med; 2006 Apr; 27(2):128-33. PubMed ID: 16612763
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Eosinophilic airway inflammation and exacerbations of COPD: a randomised controlled trial.
    Siva R; Green RH; Brightling CE; Shelley M; Hargadon B; McKenna S; Monteiro W; Berry M; Parker D; Wardlaw AJ; Pavord ID
    Eur Respir J; 2007 May; 29(5):906-13. PubMed ID: 17301099
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The association between airway eosinophilic inflammation and IL-33 in stable non-atopic COPD.
    Tworek D; Majewski S; Szewczyk K; Kiszałkiewicz J; Kurmanowska Z; Górski P; Brzeziańska-Lasota E; Kuna P; Antczak A
    Respir Res; 2018 Jun; 19(1):108. PubMed ID: 29859068
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Eosinophils in COPD-Current Concepts and Clinical Implications.
    Mycroft K; Krenke R; Górska K
    J Allergy Clin Immunol Pract; 2020 Sep; 8(8):2565-2574. PubMed ID: 32251737
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Application of Inflammatory Markers in Induced Sputum in Stable Chronic Obstructive Pulmonary Disease Patients with Positive Bronchodilation Tests.
    Guo XX; Deng NS; Chen QH; Yu HY; Ding XH; Hu SP; Nie HX
    Curr Med Sci; 2019 Aug; 39(4):560-567. PubMed ID: 31346991
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Role of local eosinophilopoietic processes in the development of airway eosinophilia in prednisone-dependent severe asthma.
    Sehmi R; Smith SG; Kjarsgaard M; Radford K; Boulet LP; Lemiere C; Prazma CM; Ortega H; Martin JG; Nair P
    Clin Exp Allergy; 2016 Jun; 46(6):793-802. PubMed ID: 26685004
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Eosinophil protein in airway macrophages: a novel biomarker of eosinophilic inflammation in patients with asthma.
    Kulkarni NS; Hollins F; Sutcliffe A; Saunders R; Shah S; Siddiqui S; Gupta S; Haldar P; Green R; Pavord I; Wardlaw A; Brightling CE
    J Allergy Clin Immunol; 2010 Jul; 126(1):61-9.e3. PubMed ID: 20639010
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The pharmacological management of asthma-chronic obstructive pulmonary disease overlap syndrome (ACOS).
    Albertson TE; Chenoweth JA; Pearson SJ; Murin S
    Expert Opin Pharmacother; 2020 Feb; 21(2):213-231. PubMed ID: 31955671
    [No Abstract]   [Full Text] [Related]  

  • 20. Inflammatory Endotype-Associated Airway Resistome in Chronic Obstructive Pulmonary Disease.
    Yi X; Li Y; Liu H; Liu X; Yang J; Gao J; Yang Y; Liang Z; Wang F; Chen D; Wang L; Shi W; Lam DCL; Stampfli MR; Jones PW; Chen R; Wang Z
    Microbiol Spectr; 2022 Apr; 10(2):e0259321. PubMed ID: 35311590
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 29.